tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Rick Bienkowski, 5 are a HOLD (17.24%), 24 are a BUY (82.76%).
Analyst Rick Bienkowski, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 8.89% that have a potential upside of 9.71% achieved within 26 days.
Rick Bienkowski’s has documented 58 price targets and ratings displayed on 5 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on NTLA, Intellia Therapeutics at 24-Jun-2024.
Analyst best performing recommendations are on VERV (VERVE THERAPEUTICS).
The best stock recommendation documented was for VERV (VERVE THERAPEUTICS) at 2/1/2023. The price target of $21 was fulfilled within 8 days with a profit of $1.07 (4.85%) receiving and performance score of 6.06.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
48
$24.69 (105.92%)
40
1 months ago
3/6 (50%)
$23.54 (96.24%)
237
Hold
31
$7.69 (32.99%)
33
1 months ago
8/9 (88.89%)
$6.54 (26.74%)
153
Hold
27
$3.69 (15.83%)
35
1 months ago
4/4 (100%)
$2.54 (10.38%)
91
Buy
57
$33.69 (144.53%)
48
4 months 15 days ago
3/6 (50%)
$33.53 (142.86%)
153
Buy
57
$33.69 (144.53%)
66
5 months 11 days ago
2/4 (50%)
$23.04 (67.84%)
4
Which stock is Rick Bienkowski is most bullish on?
What Year was the first public recommendation made by Rick Bienkowski?
